DK0428313T3 - Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser - Google Patents

Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser

Info

Publication number
DK0428313T3
DK0428313T3 DK90312117.6T DK90312117T DK0428313T3 DK 0428313 T3 DK0428313 T3 DK 0428313T3 DK 90312117 T DK90312117 T DK 90312117T DK 0428313 T3 DK0428313 T3 DK 0428313T3
Authority
DK
Denmark
Prior art keywords
asthma
treatment
analogues
well
skin disorders
Prior art date
Application number
DK90312117.6T
Other languages
Danish (da)
English (en)
Inventor
John B Cheng
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0428313T3 publication Critical patent/DK0428313T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90312117.6T 1989-11-13 1990-11-06 Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser DK0428313T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005221 WO1991007177A1 (en) 1989-11-13 1989-11-13 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders

Publications (1)

Publication Number Publication Date
DK0428313T3 true DK0428313T3 (da) 1994-03-07

Family

ID=22215372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312117.6T DK0428313T3 (da) 1989-11-13 1990-11-06 Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser

Country Status (17)

Country Link
US (1) US5342842A (ko)
EP (1) EP0428313B1 (ko)
JP (2) JPH0662412B2 (ko)
KR (1) KR930001832B1 (ko)
AT (1) ATE101040T1 (ko)
AU (1) AU627631B2 (ko)
CA (1) CA2029704C (ko)
DE (1) DE69006452T2 (ko)
DK (1) DK0428313T3 (ko)
HU (1) HU212311B (ko)
IE (1) IE63472B1 (ko)
IL (1) IL96260A (ko)
MY (1) MY111474A (ko)
NZ (1) NZ236038A (ko)
PT (1) PT95854B (ko)
WO (2) WO1991007177A1 (ko)
ZA (1) ZA909043B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
PL309257A1 (en) * 1992-12-02 1995-10-02 Pfizer Pirocatechin doethers as selective inhibitors of ped iv
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
JP2818820B2 (ja) * 1993-11-26 1998-10-30 ファイザー・インク. 抗炎症剤としての3−アリール−2−イソオキサゾリン類
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
DK0749428T3 (da) * 1994-03-09 1998-11-16 Pfizer Isooxazolinforbindelser som inhibitorer af TNF-frigivelse
JPH09505081A (ja) * 1994-03-09 1997-05-20 ファイザー・インコーポレーテッド 5−リポキシゲナーゼ阻害物質としてのイソキサゾリン化合物
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
JP4373497B2 (ja) 1996-06-19 2009-11-25 ローン−プーラン・ロレ・リミテツド 置換されたアザビシクロ化合物、ならびにtnfおよびサイクリックampホスホジエステラーゼ産生の阻害剤としてのそれらの使用
US6265402B1 (en) 1996-08-27 2001-07-24 Nikken Chemicals Co., Ltd. Use of 2-phenylmorpholin-5-one derivatives
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8416140D0 (en) * 1984-06-25 1984-08-01 Fujisawa Pharmaceutical Co Pyrimidinone derivatives
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant

Also Published As

Publication number Publication date
PT95854B (pt) 1997-11-28
MY111474A (en) 2000-06-30
HU9201575D0 (en) 1993-04-28
IE904058A1 (en) 1991-05-22
IL96260A (en) 1995-11-27
ZA909043B (en) 1992-06-24
US5342842A (en) 1994-08-30
NZ236038A (en) 1997-03-24
JP2514163B2 (ja) 1996-07-10
AU627631B2 (en) 1992-08-27
PT95854A (pt) 1991-09-13
HU212311B (en) 1996-05-28
AU6653690A (en) 1991-08-01
CA2029704C (en) 1995-02-07
JPH0748255A (ja) 1995-02-21
EP0428313A3 (en) 1991-11-06
IL96260A0 (en) 1991-08-16
JPH03209322A (ja) 1991-09-12
CA2029704A1 (en) 1991-05-14
EP0428313B1 (en) 1994-02-02
KR930001832B1 (ko) 1993-03-15
IE63472B1 (en) 1995-04-19
DE69006452T2 (de) 1994-05-11
JPH0662412B2 (ja) 1994-08-17
DE69006452D1 (de) 1994-03-17
ATE101040T1 (de) 1994-02-15
WO1991007177A1 (en) 1991-05-30
HUT70052A (en) 1995-09-28
KR910009259A (ko) 1991-06-28
EP0428313A2 (en) 1991-05-22
WO1991007178A1 (en) 1991-05-30

Similar Documents

Publication Publication Date Title
DE69527072T2 (de) Endothelin antagoniste
TW237455B (ko)
PL292101A1 (en) Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
NO304946B1 (no) Xantinderivat samt dets anvendelse
NO942452L (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
DK0428313T3 (da) Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
IE890177L (en) Piperidinyl derivatives
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
MX9702259A (es) Derivados de quinoxalina utiles en terapia.
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
IL84096A0 (en) Therapeutic agent for the treatment of peptic ulcer disease comprising a purine derivative
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
ATE58135T1 (de) 1,3-oxathianderivate.
FI103885B1 (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
RO93389A (ro) Procedeu pentru prepararea unor derivati de 4-fluortiolcarbanilida